We have investigated 100 illegal amphetamine-type stimulant (ATS) tablets seized in Japan to obtain information about the nature of these tablets abused in Japan. For physical characterization, 15 items (logo, vertical view, colour, diameter, weight, smell, etc.) were measured and a photograph was taken. For chemical characterization, the components in the tablet were identified by GC-MS and HPLC, and quantified by HPLC using an ODS-type column. The maximum content of N-methyl-3,4-methylenedioxyamphetamine (MDMA) was 189 mg/tablet and that of 3,4-methylenedioxyamphetamine (MDA) was 87 mg/tablet. The detected components, other than MDMA and MDA,, ephedrine, caffeine, ketamine, and methamphetamine. In this report, we propose a method for profiling ATS tablets.
INTRODUCTION
'Ecstasy' is the generic name for amphetaminetype stimulant (ATS) tablets that contain 3,4-methylenedioxyamphetamine (MDA), N-methyl-3,4-methylenedioxyamphetamine (MDMA), and/or N-ethyl-3,4-methylenedioxyamphetamine (MDEA). 'Ecstasy' resembles both amphetamine and mescaline in its pharmacology and toxicology.
1) 'Ecstasy' is very cheap, because it is easily prepared from many natural products, such as safrole, iso-safrole or piperonal, 2) and its abuse has spread quickly among the young. A case of MDMA/MDEA-related death was reported in Italy. 3) Recently, the amount of seized 'Ecstasy' tablets has increased remarkably in Japan. The use of ATS tablets known as 'ice' and 'ecstasy' is also spreading rapidly in east Asian countries. 4) The Bundeskriminalamt (BKA) in Germany has developed a system for profiling ATS tablets within the framework of the Central Analysis Program on Ecstasy-Tablets project. The purpose of this study was to investigate 'Ecstasy' tablets seized in Japan referring to the BKA's method.
MATERIALS AND METHODS
Materials ---Methamphetamine hydrochloride, pseudoephedrine hydrochloride, and ephedrine hydrochloride were purchased from Dainippon Pharmaceutical (Osaka, Japan). Caffeine was purchased from Iwaki Seiyaku (Tokyo, Japan). Ketamine hydrochloride was purchased from Wako (Osaka, Japan). MDA hydrochloride, MDMA hydrochloride, and MDEA hydrochloride were obtained from the reference collection of the Narcotics Control Department laboratory. Water was purified with a Milli-Q system (Nihon Millipore, Tokyo, Japan). All other solvents were of HPLC grade.
The 100 tablets that we analyzed were selected at random from among drugs seized in the Kanto district of Japan. Physical Characteristics ---The 15 items listed on the tablet identification sheet (Table 1) were measured to establish the physical characteristics of each tablet. The tablets were photographed with a digital camera "C-3040 ZOOM" (Olympus, Japan (Tables 2 and 3 ). The i.d. number and characteristics of each tablet on a tablet identification sheet were input into Microsoft Excel, and the informations on each tablet were collected in Microsoft Access with the photograph of the tablet. Instruments ---A GC/MS equipped with a Hewlett-Packard (HP) 6890 series gas chromatograph, a double-focusing mass spectrometer Mstation (JEOL, Tokyo, Japan), and data processing XMS system (JEOL) were used for identification of the components in the tablets.
A Shiseido Nanospace HPLC, equipped with a UV detector linked to a data system (S-MC, Shiseido, Tokyo, Japan), was used for qualitative and quantitative analysis of the components in the tablets. The system consisted of two Inert pumps, a column oven, an H-P valve, an autosampler, and a degassing unit. Extraction ---Each tablet was placed in a mortar made of agate and crushed to a fine powder. The powder (10 mg) was dissolved in 8 ml of phosphate buffer, pH 7.0, by shaking for 5 min. The solution was centrifuged for 10 min at 3500 rpm, and 100 µl of the supernatant liquid was transferred to a small autosampler vial for HPLC analysis. Half of the solution (4 ml) was used for the identification of the basic compound (ephedrine, MDA, MDMA, etc.), and the other half was used for the identification of neutral compound (caffeine). One milliliter of 10% Na 2 CO 3 solution was added to adjust half of solution (4 ml) to pH 10.0, and the mixture was extracted 
GC/MS data number with 3 ml of n-hexane (or chloroform) by shaking for 5 min. The solution was centrifuged for 10 min at 3500 rpm, and the organic layer was transferred to a vial for GC/MS analysis. For identification of caffeine by GC/MS, the remaining solution (3.9 ml, pH 7.0) was extracted with 3 ml of chloroform. GC/MS Analysis ---An Ultra-2 fused-silica capillary column (30 m × 0.2 mm × 0.33 µm, HP) was inserted directly into the ion source of the mass spectrometer, and analysis was performed in the splitless mode with helium as the carrier gas. The GC program was run from 50°C (1 min) to 300°C (4 min) at 10°C/min, with the injection port at 250°C. Electron-impact ionization mass conditions were set as follows: ionizing energy, 70 eV; ionization current, 300 µA; and ion-source temperature, 300°C. Mass spectra were obtained using the scanning mode. HPLC Analysis ---Chromatographic separation was achieved using an ODS-type semimicrocolumn (CAPCELL PAK C18 UG 120 S5, 250 mm × 1.5 mm i.d.) The mobile phase used for ephedrine, MDA, MDMA, methamphetamine, ketamine, and MDEA was 5 mmol/l SDS in 20 mmol/l KH 2 PO 4 -CH 3 CN (65 : 35). The mobile phase used for caffeine was H 2 O-methanol (7 : 3). The flow rate was maintained at 0.1 ml/min. Separation was carried out at 50°C for ephedrine, MDA, MDMA, methamphetamine, ketamine, and MDEA and 35°C for caffeine. The monitoring wavelength was 210 nm for ephedrine, MDA, MDMA, methamphetamine, ketamine, and MDEA and 254 nm for caffeine. Validation ---Linearity was examined using standard aqueous solutions of ephedrine hydrochloride, MDA hydrochloride, MDMA hydrochloride, methamphetamine hydrochloride, MDEA hydrochloride, and caffeine at concentrations of 0.2, 0.4, 0.6, and 0.8 mg/ml. A recovery test was performed with tablet powder (10 mg) that contained MDMA alone by adding 8 ml of phosphate buffer solution (pH 7.0) containing 4 mg or 6 mg each of ephedrine, caffeine, meth- 
RESULTS AND DISCUSSION

Physical Characteristics
To aid in quick comparison, full-color photographs of all tablets are shown in Fig. 1 . The photo- Table 4 .
Chemical Characteristics
The forensic identification of illegal drugs consists of at least two independent tests, one of which must be a confirmatory instrumental test. In this report, the active ingredients in each tablet were iden- tablet contained MDEA 89 mg/tablet (calculated as MDEA hydrochloride). Twenty-six tablets contained two, three or four active ingredients. The contents of active ingredients in each tablet are shown in the photograph collection. Table 6 shows the amounts of MDMA found in illegal tablets with the same logo and color. The MDMA content of tablets seized on a drug criminal case was relatively consistent. Comparisons of individual tablets with the same color and logo seized on different drug criminal cases indicate that the MDMA percent purity was inconsistent.
We have confirmed that 'ecstasy' tablets abused phetamine from illegal tablets. Ephedrine has low solubility in n-hexane, and it was impossible to detect ephedrine in n-hexane extracts by GC/MS. We therefore used chloroform for effective extraction of the active ingredients from illegal tablets containing ephedrine. Quantitative analysis was done using HPLC. For the present purpose, we modified the method that we previously reported for the impurity profiling of ephedrines in methamphetamine. 5) We investigated the optimum temperature of the column oven to obtain good separation of six components (pseudoephedrine hydrochloride, ephedrine hydrochloride, MDA hydrochloride, MDMA hydrochloride, MDEA hydrochloride, and methamphetamine hydrochloride) in a short time and found that the optimum temperature was 50°C. An HPLC chromatogram of a standard solution is shown in Fig. 2. (The HPLC chromatogram for caffeine is not shown.)
Good linearity of the method was confirmed over the concentration range of 0.2-0.8 mg/ml (r 2 = 0.996-0.999 for seven compounds).
The recovery of standard samples of ephedrine hydrochloride, caffeine, methamphetamine hydrochloride, MDA hydrochloride, MDMA hydrochloride, and MDEA hydrochloride added to tablet powder (10 mg) is shown in Table 5 .
Sixty-eight tablets contained MDMA as the sole active ingredient. The content range (calculated as MDMA hydrochloride) was 54-189 mg/tablet. Five tablets contained MDA alone. The range (calculated as MDA hydrochloride) was 68-87 mg/tablet. One in Japan contain a high concentration of MDMA. In a report on tablets seized in the U.K., the MDMA content ranged from 88 to 140 mg/tablet. 6) Nineteen tablets contained ephedrine, caffeine, ketamine, and methamphetamine as active ingredients other than MDMA, MDA, or MDEA. Ketamine is a psychedelic drug that can give rise to a psychological dependence. 7) These 'ecstasy' tablets may have unexpected effects arising from mutual interactions among ephedrine, caffeine, ketamine, or methamphetamine. In this conclusion, we propose the following method for profiling ATS tablets:
Measure the 15 items in the tablet identification sheet.
Photograph the tablet with a digital camera. 
